Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T16:57:10.002Z.
Calculation as of: 2026-10-06T16:57:10.002Z.
Quote observation: 2026-10-06T16:55:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 84f755396c9cc6b6c9535f897ba0f48fef5a33e79b5fb4c136097311f2feddf3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-05-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.10M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03M
EBITDA Yield
N/A
TTM Avg
86.52%
3Y Avg
86.52%
5Y Avg
86.52%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IM Cannabis Corp. (IMCC) | $1.15M | N/A | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.14M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.25M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | N/A | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | N/A | 86.52% | 86.52% | 86.52% |
| NewcelX Ltd. (NCEL)vs › | $1.32M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.34M | N/A | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $881948.00 | N/A | 0.07% | 0.06% | 0.06% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2024-05-08 | 21.23% |
| 2024-05-07 | 20.25% |
| 2024-05-06 | 20.18% |
| 2024-05-03 | 19.08% |
| 2024-05-02 | 18.84% |
| 2024-05-01 | 16.73% |
| 2024-04-30 | 19.45% |
| 2024-04-29 | 24.18% |
| 2024-04-26 | 24.28% |
| 2024-04-25 | 24.05% |
| 2024-04-24 | 24.82% |
| 2024-04-23 | 23.99% |
| 2024-04-22 | 23.45% |
| 2024-04-19 | 23.30% |
| 2024-04-18 | 23.61% |
| 2024-04-17 | 24.12% |
| 2024-04-16 | 25.06% |
| 2024-04-15 | 23.80% |
| 2024-04-12 | 22.91% |
| 2024-04-11 | 21.31% |
| 2024-04-10 | 21.13% |
| 2024-04-09 | 20.55% |
| 2024-04-08 | 18.49% |
| 2024-04-05 | 19.45% |
| 2024-04-04 | 17.01% |
| 2024-04-03 | 18.12% |
| 2024-04-02 | 20.86% |
| 2024-04-01 | 21.08% |
| 2024-03-28 | 3.54% |
| 2024-03-27 | 3.97% |
| 2024-03-26 | 3.80% |
| 2024-03-25 | 3.99% |
| 2024-03-22 | 3.91% |
| 2024-03-21 | 4.53% |
| 2024-03-20 | 4.43% |
| 2024-03-19 | 4.46% |
| 2024-03-18 | 4.39% |
| 2024-03-15 | 4.16% |
| 2024-03-14 | 4.33% |
| 2024-03-13 | 4.46% |
| 2024-03-12 | 4.50% |
| 2024-03-11 | 4.41% |
| 2024-03-08 | 4.41% |
| 2024-03-07 | 4.41% |
| 2024-03-06 | 4.40% |
| 2024-03-05 | 4.43% |
| 2024-03-04 | 4.41% |
| 2024-03-01 | 4.34% |
| 2024-02-29 | 4.34% |
| 2024-02-28 | 4.32% |
| 2024-02-27 | 4.24% |
| 2024-02-26 | 4.37% |
| 2024-02-23 | 4.32% |
| 2024-02-22 | 4.32% |
| 2024-02-21 | 4.15% |
| 2024-02-20 | 4.19% |
| 2024-02-16 | 4.44% |
| 2024-02-15 | 4.51% |
| 2024-02-14 | 4.48% |
| 2024-02-13 | 4.63% |
| 2024-02-12 | 4.59% |
| 2024-02-09 | 4.72% |
| 2024-02-08 | 4.74% |
| 2024-02-07 | 4.76% |
| 2024-02-06 | 4.81% |
| 2024-02-05 | 4.80% |
| 2024-02-02 | 4.78% |
| 2024-02-01 | 4.74% |
| 2024-01-31 | 4.70% |
| 2024-01-30 | 4.55% |
| 2024-01-29 | 4.36% |
| 2024-01-26 | 4.34% |
| 2024-01-25 | 4.98% |
| 2024-01-24 | 5.07% |
| 2024-01-23 | 5.02% |
| 2024-01-22 | 4.94% |
| 2024-01-19 | 4.88% |
| 2024-01-18 | 4.72% |
| 2024-01-17 | 4.59% |
| 2024-01-16 | 4.63% |
| 2024-01-12 | 4.52% |
| 2024-01-11 | 4.59% |
| 2024-01-10 | 4.47% |
| 2024-01-09 | 4.40% |
| 2024-01-08 | 4.32% |
| 2024-01-05 | 4.21% |
| 2024-01-04 | 4.22% |
| 2024-01-03 | 4.37% |
| 2024-01-02 | 4.28% |
| 2023-12-29 | 4.21% |
| 2023-12-28 | 4.29% |
| 2023-12-27 | 4.30% |
| 2023-12-26 | 4.28% |
| 2023-12-22 | 4.28% |
| 2023-12-21 | 4.31% |
| 2023-12-20 | 4.06% |
| 2023-12-19 | 4.33% |
| 2023-12-18 | 4.15% |
| 2023-12-15 | 4.07% |
| 2023-12-14 | 4.22% |
| 2023-12-13 | 4.20% |
| 2023-12-12 | 4.17% |
| 2023-12-11 | 4.14% |
| 2023-12-08 | 4.18% |
| 2023-12-07 | 4.14% |
| 2023-12-06 | 4.06% |
| 2023-12-05 | 3.98% |
| 2023-12-04 | 4.00% |
| 2023-12-01 | 3.97% |
| 2023-11-30 | 3.99% |
| 2023-11-29 | 3.98% |
| 2023-11-28 | 4.07% |
| 2023-11-27 | 4.03% |
| 2023-11-24 | 3.99% |
| 2023-11-22 | 4.04% |
| 2023-11-21 | 3.94% |
| 2023-11-20 | 3.98% |
| 2023-11-17 | 3.94% |
| 2023-11-16 | 3.98% |
| 2023-11-15 | 3.86% |
| 2023-11-14 | 3.84% |
